Science and Technology Quiz Questions 2024

Please follow and like us:

Science and Technology Quiz Questions 2024 With Answers

One-liner questions:

What action has the Yeon Suk Yeol administration taken to address the doctor shortage?
How many medical school admissions does the Yeon Suk Yeol administration plan to add per year?
How many additional medical school students will be admitted next year in South Korea?
What did Dr. Jitendra Singh say about women-led startups in India?
What is the target year for India to become a Viksit Bharat, as mentioned by Dr. Jitendra Singh?
What role do startups play in India’s roadmap to becoming a Viksit Bharat by 2047?
Who inaugurated the eight new NIDHI Inclusive Technology Business Incubators?
Where was the new DST-NIDHI website launched?
What did Dr. Singh direct all innovators to work toward?
What condition did US researchers treat to give functional eyesight to patients for the first time?
What gene mutation causes LCA1 blindness?
What challenges do individuals with LCA1 face in their daily lives?
Who developed the gene therapy for LCA1?
What were the side effects of the gene therapy for LCA1?
What was the result for patients receiving the maximum dosage of the LCA1 gene therapy?
How did patients describe the impact of the LCA1 treatment?
What approval did the Health Ministry give regarding tuberculosis treatment in India?
How many MDR-TB patients in India will benefit from the new regimen?
What is the name of the new anti-TB drug regimen approved by the Health Ministry?
What is the goal of India’s Health Ministry regarding tuberculosis elimination?
By how many years does India aim to eliminate TB before the global UN target?
Which organization is preparing the nationwide roll-out plan for the new TB regimen?
What new drug is included in the BPaLM regimen?
What drugs make up the four-drug combination in the new MDR-TB treatment?
How long did traditional MDR-TB treatments last compared to the new regimen?
How long does the BPaLM regimen take to cure MDR-TB?
What has the government said about the effectiveness of the BPaLM regimen?
What type of review was conducted to validate the BPaLM regimen?
What is the purpose of India’s National Tuberculosis Elimination Programme (NTEP)?
When and where did PM Modi first announce India’s goal to end TB by 2025?

Answers:

The Yeon Suk Yeol administration has vowed to increase the medical school admissions quota to address the doctor shortage.
The administration plans to add 2,000 seats per year over the next five years.
A hike of 1,500 students will be finalized for next year.
Dr. Jitendra Singh said women-led startups will place India on the global map.
The target year for India to become a Viksit Bharat is 2047.
Startups play a crucial role in the journey towards a Viksit Bharat.
Dr. Jitendra Singh inaugurated eight new NIDHI Inclusive Technology Business Incubators.
The new DST-NIDHI website was launched at IIT Delhi.
Dr. Singh directed all innovators to contribute to realizing the vision of a Viksit Bharat by 2047.
US researchers treated patients with LCA1, a rare inherited blindness.
LCA1 is caused by mutations in the GUCY2D gene.
Individuals with LCA1 have difficulty reading, driving, or navigating their environment.
The gene therapy was developed by scientists at the University of Florida.
The side effects were minimal, with inflammation treated using steroids.
Patients administered the maximum dosage of gene therapy showed remarkable improvement in vision.
Many patients described the treatment as “like a light had been switched on.”
The Health Ministry approved a shorter and more effective regimen for multi-drug-resistant tuberculosis (MDR-TB).
Around 75,000 MDR-TB patients in India will benefit from the new regimen.
The new regimen is called the BPaLM regimen.
The goal is to eliminate TB by 2025.
India aims to eliminate TB five years ahead of the global target.
The Central TB Division of the Health Ministry is preparing the nationwide roll-out plan.
Pretomanid is the new anti-TB drug included in the BPaLM regimen.
The four-drug combination includes Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin.
Traditional MDR-TB treatments lasted up to 20 months.
The BPaLM regimen takes just six months to cure MDR-TB.
The government has proven the BPaLM regimen to be safe, more effective, and quicker.
A thorough review of evidence was conducted to validate the BPaLM regimen.
The NTEP aims to reduce TB burden in India by 2025.
PM Modi announced India’s goal to end TB by 2025 at the Delhi End TB Summit in March 2018.